Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rTPA in acute ischemic stroke
IRCT20160318027097N10Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by Ardabil University of Medical Sciences. Primary endpoint: Change in NIH Stroke Scale score at month 3. Started May 2018; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20160318027097N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160318027097N10.